Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Motorpoint reinstates dividend after swing to profit

(Sharecast News) - Vehicle retailer Motorpoint has reinstated its dividend after swinging to a profit in the year ended 31 March on the back of solid revenue growth, increased use of data-led analytics and improved stock management. The company, which last paid a dividend in early 2020, said it would be paying shareholders 1p per share for the year to complement its share buyback plan announced in April, and pledged a "progressive dividend policy" going forward.

Revenues for the year rose to £1.17bn from £1.09bn previously, as the number of vehicles sold increased 12.4% to 87,700, while the number of days in stock fell to 43 from 45.

Top-line growth, in addition to "significant variable cost savings", helped the company record a pre-tax profit of £4.1m, compared with a loss of £10.4m previously.

Chief executive Mark Carpenter said he was "extremely pleased" with the group's performance after several years of "considerable economic headwinds that have hampered our industry".

For the current year, Motorpoint said it has seen growth in retail volumes over April and May despite tougher comparatives with last year, while profitability has increased year-on-year.

"We expect ongoing macroeconomic pressures to generally ease, with further, moderate reductions in interest rates and supply of nearly new used vehicles should continue to slowly increase. However, we remain mindful consumer confidence in the near term remains uncertain. We will continue to prudently manage the cost base despite labour inflation headwinds," Carpenter said.

Motorpoint shares were up 1.2% at 0822 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.